Kenneth Kim, MD
Allergy & Immunology · Long Beach, CANPI 1205833563
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (43.1%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 21.9%. 2025 is the largest year on record at $2,982, 3.1 times the $972 reported in 2019.
Across 196 payments — averaging $65.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$3K
- Shionogi Inc$2K
- Novartis$2K
- AstraZeneca$2K
- CSL Behring$1K
- Modernatx, Inc.$1K
- plus $2K from 24 others
Across 848 payments — averaging $21,850 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$9.5M
- Regeneron$3M
- Pfizer$1.7M
- GSK$1.3M
- Amgen$895K
- AstraZeneca$504K
- plus $1.5M from 17 others
What the payments were for
- Consulting fees$2,20017%
- Speaking & faculty fees$2,00116%
- Travel & lodging$3,03724%
- Food & beverage$5,51343%
- Education$340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $2,798 |
| Shionogi Inc | 1 | $1,715 |
| Novartis | 17 | $1,659 |
| AstraZeneca | 15 | $1,516 |
| CSL Behring | 56 | $1,420 |
| Modernatx, Inc. | 7 | $1,200 |
| Sanofi | 15 | $532 |
| GSK | 13 | $342 |
| Amgen(2 entities) | 5 | $301 |
| Genentech USA, Inc. | 10 | $213 |
| Organon | 1 | $133 |
| Optinose US, Inc. | 7 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $120 |
| Pfizer | 6 | $100 |
| Grifols USA, LLC | 4 | $95 |
| Incyte Corporation | 2 | $79 |
| Teva Pharmaceuticals USA, Inc. | 4 | $67 |
| Pharming Healthcare, Inc. | 3 | $63 |
| Alk-abello, Inc | 2 | $47 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $39 |
| Dentsply IH Inc. | 1 | $37 |
| Gilead | 1 | $33 |
| Biocryst US Sales Co., LLC | 1 | $27 |
| Shire North American Group Inc | 1 | $22 |
| Bio Products Laboratory USA, Inc. | 1 | $21 |
| Galderma Laboratories, L.p. | 1 | $20 |
| LEO Pharma Inc. | 1 | $19 |
| Merck | 1 | $16 |
| Blueprint Medicines Corporation | 1 | $16 |
| Octapharma USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,785 in reported general payments places this provider in the 80th percentile of 426 allergy & immunology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 23 | $626 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $343 |
| Montelukast Sodium | 32 | $265 |
| Fluticasone Propionate | 12 | $232 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Long Beach
- Steven MeltzerLong Beach$21K
- Raffi TachdjianSanta Monica$3.7M
- Bob GengSan Diego$3.3M
- Vinay MehtaLaguna Niguel$1.3M
- Andrew WhiteSan Diego$752K
- Marc RiedlSan Diego$725K
- Katharine WoessnerSan Diego$581K
- Brian Modenala Jolla$453K
- Heena Shah PatelUpland$428K
- Jacob OffenbergerGranada Hills$419K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.